Antibodies

are an important component of the immune system. The in vitro production of the up-to-date therapeutic monoclonal antibodies is currently achieved in hybrid production facilities, whereby the USP is increasingly performed with single-use systems. Mainly fed-batch processes with temperature shifts are applied, reaching antibody concentrations between 2 und 5 g L^-1. See biopharmaceuticals.